Hepatocellular Carcinoma (HCC)

Introduction

More than 600,000 people die from Hepatocellular Carcinoma (HCC) each year. Worldwide research on the disease needs to be intensified in both the medical and pharmaceutical fields, especially with a focus on providing help to areas where resources are limited.

Translated Versions

English	French	Mandarin
Portuguese	Russian	Spanish

Feedback

Review Team

• Peter Ferenci (Chair, Austria)
• Michael Fried (Switzerland)
• Douglas Labrecque (USA)
• Jordi. Bruix (Spain)
• Morris Sherman (Canada)
• Masao Omata (Japan)
• Jenny Heathcote (Canada)
• Teehra Piratsivuth (Thailand)
• Mike Kew (South Africa)
• Jesse A. Otegbayo (Nigeria)
• S.S. Zheng (China)
• Shiv Kumar Sarin (India)
• Saeed S. Hamid (Pakistan)
• Salma Barakat Modawi (Sudan)
• Wolfgang Fleig (Germany)
• Suliman Fedail (Sudan)
• Alan Thomson (Canada)
• Aamir Khan (Pakistan)
• Peter Malfertheiner (Germany)
• George Lau (Hong Kong)
• Flair J. Carillo (Brazil)
• Justus H. Krabshuis (France)
• Anton Le Mair (The Netherlands)

« Return to Guidelines